Farringdon Capital Ltd. Purchases New Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Farringdon Capital Ltd. acquired a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 16,346 shares of the health services provider’s stock, valued at approximately $149,000.

Other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its position in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after purchasing an additional 1,029,829 shares during the period. Renaissance Technologies LLC increased its stake in Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider’s stock valued at $51,582,000 after purchasing an additional 763,265 shares in the last quarter. Nisa Investment Advisors LLC increased its position in shares of Teladoc Health by 20,936.8% in the 4th quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider’s stock valued at $3,874,000 after buying an additional 424,180 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider’s stock worth $22,213,000 after buying an additional 384,528 shares during the period. Finally, Wealthfront Advisers LLC bought a new position in Teladoc Health during the fourth quarter worth about $3,364,000. 76.82% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on TDOC shares. Piper Sandler cut their price objective on Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, February 27th. Royal Bank of Canada upped their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Oppenheimer dropped their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a report on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a report on Thursday, February 27th. Finally, The Goldman Sachs Group cut their price target on Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Eleven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $10.94.

Teladoc Health Stock Performance

Shares of TDOC opened at $6.83 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a 50-day moving average of $9.17 and a 200-day moving average of $9.63. The company has a market cap of $1.20 billion, a PE ratio of -1.18 and a beta of 1.73. Teladoc Health, Inc. has a one year low of $6.61 and a one year high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. As a group, equities analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction that occurred on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the completion of the sale, the insider now directly owns 64,308 shares in the company, valued at $541,473.36. This trade represents a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.